Literature DB >> 15582248

Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy?

Dorothea Weckermann1, Friedhelm Wawroschek, Rolf Harzmann.   

Abstract

OBJECTIVES: In men with low risk prostate cancer the need for pelvic lymph node dissection is controversial. Therefore, we examined how many men with favorable preoperative risk factors had positive lymph nodes.
METHODS: 235 men with preoperative PSA < or =10 ng/ml, Gleason score < or =6 and positive biopsies in only one lobe, had radio-guided pelvic sentinel lymph node (SLN) dissection and radical retropubic prostatectomy (RRP) or-in case of no positive lymph nodes detected-a transperineal I(125) seed implantation. Eighty-four men with positive biopsies in both lobes and identical PSA and Gleason score had SLN dissection and RRP.
RESULTS: In 187 men with positive biopsies in one lobe RRP was performed. Sixteen patients had positive lymph nodes. Median 6 SLN (mean 6.8) and 6 non-sentinel lymph nodes (NSLN) (mean 7.3) were dissected. All men with positive lymph nodes also had positive SLN. Eighty-four men with positive biopsies in both lobes had RRP. Nine men had positive lymph nodes (10.7%). A median of 6 SLN (mean 6.6) and 5 NSLN (mean 7.5) were dissected. All men with positive nodes had a single positive SLN.
CONCLUSIONS: In patients with PSA < or =10 ng/ml and biopsy Gleason score < or =6, positive lymph nodes were identified by radio-guided surgery in 6.8% (positive biopsies in one lobe) and 10.7% (positive biopsies in both lobes). Up to 4 positive SLN were found. Therefore, we suggest not to dispense with an operative lymph node staging, even in low risk disease.

Entities:  

Mesh:

Year:  2005        PMID: 15582248     DOI: 10.1016/j.eururo.2004.07.017

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

1.  Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure.

Authors:  Isabelle Brenot-Rossi; Dominique Rossi; Benjamin Esterni; Serge Brunelle; Guillaume Chuto; Cyrille Bastide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-09       Impact factor: 9.236

Review 2.  Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm.

Authors:  Gilles Créhange; Chien Peter Chen; Charles C Hsu; Norbert Kased; Fergus V Coakley; John Kurhanewicz; Mack Roach
Journal:  Cancer Treat Rev       Date:  2012-06-15       Impact factor: 12.111

Review 3.  [Value of sentinel node biopsy for urological tumors].

Authors:  F Wawroschek; R Harzmann; D Weckermann
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

4.  Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: evidentiary base.

Authors:  Joseph L Chin; John Srigley; Linda A Mayhew; R Bryan Rumble; Claire Crossley; Amber Hunter; Neil Fleshner; Bish Bora; Robin McLeod; Sheila McNair; Bernard Langer; Andrew Evans
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

5.  [Sentinel lymph node dissection in prostate cancer. Experience after more than 800 interventions].

Authors:  D Weckermann; M Hamm; R Dorn; T Wagner; F Wawroschek; R Harzmann
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

6.  [Value of lymphadenectomy for limited nodal recurrence of prostate cancer after local therapy with curative intent].

Authors:  I Wolff; M-O Grimm; M Wirth
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

7.  Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.

Authors:  Ute Ganswindt; Frank Paulsen; Stefan Corvin; Kai Eichhorn; Stefan Glocker; Ilse Hundt; Mattias Birkner; Markus Alber; Aristotelis Anastasiadis; Arnulf Stenzl; Roland Bares; Wilfried Budach; Michael Bamberg; Claus Belka
Journal:  BMC Cancer       Date:  2005-07-28       Impact factor: 4.430

Review 8.  Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?

Authors:  O R Brouwer; H G van der Poel; R F Bevers; E J van Gennep; S Horenblas
Journal:  Clin Transl Imaging       Date:  2016-07-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.